The book provides treatment recommendations for bipolar patients, a review of evidence about bipolar disorder, and states research needs

The aim of the American Psychiatric Association Practice Guideline series is to improve patient care. Guidelines provide a comprehensive synthesis of all available information relevant to the clinical topic. Practice guidelines can be vehicles for educating psychiatrists, other medical and mental health professionals, and the general public about appropriate and inappropriate treatments. The series also will identify those areas in which critical information is lacking and in which research could be expected to improve clinical decisions. The Practice Guidelines are also designed to help those charged with overseeing the utilization and reimbursement of psychiatric services to develop more scientifically based and clinically sensitive criteria.

Since the 1990 publication of Goodwin and Jamison's classic text on mania and bipolar and unipolar depression, Manic-Depressive Illness, there have been a number of significant advances in the research, diagnosis, and treatment of mania and bipolar disorder. Developed and written by experts at the forefront of these advances, Mania: Clinical and Research Perspectives provides a comprehensive overview of all recent developments on all aspects of mania. Mania is divided into three sections: diagnostic considerations, biological aspects, and treatment. "Diagnostic Considerations" includes coverage of the diagnostic revisions in DSM-IV, special comorbidity issues in children and substance abuse, the differentiation of mood swing from bipolar disorder, and generational change and genetic linkage. "Biological Aspects" reviews the current state of knowledge in biochemistry and biological techniques such as gamma-aminobutyric acid (GABA) and brain imaging. "Treatment" thoroughly surveys all major treatment regimens for mania, including new drug therapies such as carbamazepine, valproate, clozapine, risperidone, verapamil, and nimodipine. This section also details new findings on the use of lithium and the risks for pregnant women and advances in psychotherapy. The book concludes with a summary that provides a historical perspective and directions for further research. With the comprehensive coverage provided in Mania: Clinical and Research Perspectives, readers will be able to improve patient care through advanced diagnosis and treatment.

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

Developed by the APA to assist in clinical decision making, the "Practice Guidelines" series has become an invaluable resource to help benchmark care strategies for 11 common mental disorders. The APA makes "Practice Guidelines" available to help improve patient care and give members access to the latest information and research. Intended as a professional resource and not a "standard of care," the "Practice Guidelines" provide convenient summaries of what we know about key mental disorders and the effectiveness of specific treatments. The eleven "Practice Guidelines" are: Alzheimer's Disease and Other Dementias Of Late Life Bipolar Disorder, Second Edition Borderline Personality Disorder Delirium Eating Disorders, Second Edition HIV/AIDS Major Depressive Disorder, Second Edition Panic Disorder Psychiatric Evaluation Of Adults Schizophrenia Substance Use Disorder: Alcohol, Cocaine, Opioids These guidelines help you: Understand clinical features and symptoms Make a confident differential diagnosis Evaluate interventions commonly used to treat specific disorders Select the appropriate site of service Educate the patient and family Assess the efficacy and risks of available medications Develop an individualized treatment plan

Bipolar disorder is a chronic and debilitating mental illness affecting a significant proportion of the world's population. It is associated with significant impairments in health-related quality of life and psychosocial functioning, and has significant illness-related morbidity and heightened mortality rates due to medical comorbidities and suicide. The management of this disorder requires a complex combination of pharmacological and psychosocial interventions which can be challenging for clinicians. Written by world experts in the field of bipolar disorder, The Treatment of Bipolar Disorder: Integrative Clinical Strategies and Future Directions provides readers with a concise and comprehensive guide to the integrative management of bipolar disorder. This resource contains 31 chapters on the various management choices available, from both established and novel treatment areas, such as psychoeducation, psychotherapeutic interventions, neuromodulatory approaches and novel therapeutic targets. The complexity and diversity of the management choices available makes this a continually evolving field and necessitates forward thinking. By both discussing the current management of bipolar disorder, and the future developments available, this resource provides all clinicians working with patients with bipolar disorder an up-to-date and reflective guide to its management and what the future holds.

Bipolar disorders were once considered rare in children and adolescents. A growing body of scientific evidence now suggests that they may be more prevalent in this group than previously believed. At the same time, the practitioner faces significant clinical challenges in both the assessment processes and also the implementation of a treatment plan. A paucity of treatment manuals and pharmacological algorithms providing practical guidance makes the task of the clinician even more difficult, despite the fact that more is known about the assessment, neurobiology and treatment of children and adolescents with bipolar disorder than ever before. Written by three distinguished experts, this book conveys to clinicians all the information currently available in this area. They review both the neuroscience and also the integration of rational, practical, pharmacological and psychosocial interventions. Based on what is known, a sound approach to the assessment of these youngsters can be developed. Similarly, available evidence allows practitioners to ground their treatment protocols solidly on scientific knowledge. Concise and authoritative, Pediatric Bipolar Disorders will give the reader a practical approach to both the art and science of providing the best possible clinical care to children and adolescents with the disorder. This book is written primarily for clinical psychiatrists, but will also be of interest to non-specialist doctors and other members of the health care team.